Skip Navigation

Skip Navigation

Issue No. 26  | June 22, 2012
View HTML version

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.

Globe of the earth

News About NIH-Sponsored Studies

The National Institutes of Health (NIH) recently released news of findings from three HIV-related research studies:

  • June 20, 2012
    Adding Nevirapine to HIV Regimen Halves Newborn Transmission Rate
    “Findings from NIH network support shift in prevention guidelines”

    For more information, read the NIH press release.
     
  • June 20, 2012
    Children Exposed to HIV in the Womb at Increased Risk for Hearing Loss
    “NIH study shows risk greater for HIV-infected children than for uninfected peers”

    For more information, read the NIH press release.
     
  • June 19, 2012
    NIH Study Finds HIV-Positive Young Men at Risk of Low Bone Mass
    “Researchers recommend monitoring, exercise, vitamin D to prevent future fracture risk”

    For more information, read the NIH press release.
     


FDA Approves Generic Formulation of Abacavir Tablets

On June 18, 2012, the Food and Drug Administration (FDA) approved a generic formulation of abacavir tablets, 300 mg. FDA approval means this generic formulation of abacavir may now be marketed in the United States.

FDA provides a comprehensive list of the approved generic formulations of antiretroviral drugs used to treat HIV infection.


Join AIDSinfo in Observing National HIV Testing Day

June 27, 2012, is the 18th annual observance of National HIV Testing Day. The purpose of this day is to promote HIV testing. The Centers for Disease Control and Prevention (CDC) reports that of the more than one million people in the United States living with HIV, one out of five do not know that they are infected.

HIV testing is a critical component of HIV/AIDS prevention, treatment, and care. According to CDC, at least one in three people in the United States who test positive for HIV is tested too late to get the full advantage of treatment. Early HIV testing reduces the spread of HIV, extends life expectancy, and reduces costs of care.

For information and resources about HIV testing, visit the AIDSinfo webpage highlighting National HIV Testing Day [en español].


Message for At-a-Glance E-Newsletter Subscribers

AIDSinfo inadvertently forwarded the most recent issue of al instante, the Spanish-language version of our At-a-Glance e-newsletter, to all of our e-newsletter subscribers.

We regret any inconvenience to those who are not subscribed to the Spanish-language e-newsletter.


Twitter - Stay connected FaceBook - Stay connected
ClinicalTrials.gov Info

Subscribe Info

Contact AIDSinfo
Download Adobe Acrobat(R) Reader TM to view PDF files located on this site.
ISSN 1558-3228